WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996007450) ENHANCEMENT OF THROMBOLYSIS WITH EXTERNAL ULTRASOUND
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/007450    International Application No.:    PCT/US1995/011372
Publication Date: 14.03.1996 International Filing Date: 08.09.1995
Chapter 2 Demand Filed:    01.04.1996    
IPC:
A61B 17/22 (2006.01), A61B 19/00 (2006.01), A61N 7/00 (2006.01)
Applicants: CORAJE, INC. [US/US]; 601 Montgomery Street #900, San Francisco, CA 94111 (US)
Inventors: CARTER, Robert, E.; (US)
Agent: HACKLER, Walter, A.; Suite B, 2372 S.E. Bristol, Newport Beach, CA 92660 (US)
Priority Data:
303,858 09.09.1994 US
Title (EN) ENHANCEMENT OF THROMBOLYSIS WITH EXTERNAL ULTRASOUND
(FR) AMELIORATION D'UNE THROMBOLYSE A L'AIDE D'ULTRASONS EXTERNES
Abstract: front page image
(EN)Apparatus (10) and methods are provided for enhancing the thrombolytic action of a thrombolytic agent and removing a thrombosis (22) by introducing a select dose of thrombolytic agent proximate the thrombosis (22) disposed within a vessel of a body (20) and radiating the thrombosis with ultrasound generated exterior to the body (20) to effect removal of the thrombosis (22) in less time than the time required by activity of the selected dose of thrombolytic agent without the ultrasonic radiation of the thrombosis (22).
(FR)Cette invention se rapporte à un appareil (10) et a des procédés pour améliorer l'action thrombolytique d'un agent thrombolytique et pour dissoudre une thrombose (22), en introduisant une dose choisie d'un agent thrombolytique à proximité de la thrombose (22) se trouvant dans un vaisseau du corps (20) d'un patient, et en exposant la thrombose à des ultrasons produits à l'extérieur du corps (20) du patient, pour obtenir l'élimination de la thrombose (22) en moins de temps que ce qui est nécessaire par l'action de la dose choisie d'agent thrombolytique sans l'exposition de la thrombose (22) aux ultrasons.
Designated States: AM, AT, AU, BB, BG, BR, BY, CA, CH, CN, CZ, DE, DK, EE, ES, FI, GB, GE, HU, JP, KE, KG, KP, KR, KZ, LK, LR, LT, LU, LV, MD, MG, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SI, SK, TJ, TT, UA, UZ, VN.
African Regional Intellectual Property Organization (KE, MW, SD, SZ, UG)
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)